Technical Analysis for IQV - IQVIA Holdings, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 219.09 | -1.51% | -3.36 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
Expansion Breakdown | Bearish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | -1.51% | |
Stochastic Reached Oversold | Weakness | -1.51% |
Alert | Time |
---|---|
Down 1 ATR | 1 day ago |
60 Minute Opening Range Breakdown | 1 day ago |
Down 2 % | 1 day ago |
2x Volume Pace | 1 day ago |
1.5x Volume Pace | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/02/2024
IQVIA Holdings, Inc. Description
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 261.73 |
52 Week Low | 167.42 |
Average Volume | 918,968 |
200-Day Moving Average | 221.06 |
50-Day Moving Average | 234.72 |
20-Day Moving Average | 228.31 |
10-Day Moving Average | 226.66 |
Average True Range | 4.90 |
RSI (14) | 34.64 |
ADX | 19.57 |
+DI | 13.11 |
-DI | 31.47 |
Chandelier Exit (Long, 3 ATRs) | 222.87 |
Chandelier Exit (Short, 3 ATRs) | 231.34 |
Upper Bollinger Bands | 236.02 |
Lower Bollinger Band | 220.60 |
Percent B (%b) | -0.1 |
BandWidth | 6.75 |
MACD Line | -2.96 |
MACD Signal Line | -2.28 |
MACD Histogram | -0.6807 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 229.44 | ||||
Resistance 3 (R3) | 229.78 | 226.66 | 227.72 | ||
Resistance 2 (R2) | 226.66 | 224.03 | 226.50 | 227.14 | |
Resistance 1 (R1) | 222.88 | 222.40 | 221.32 | 222.54 | 226.56 |
Pivot Point | 219.76 | 219.76 | 218.99 | 219.60 | 219.76 |
Support 1 (S1) | 215.98 | 217.13 | 214.42 | 215.64 | 211.62 |
Support 2 (S2) | 212.86 | 215.50 | 212.70 | 211.04 | |
Support 3 (S3) | 209.08 | 212.86 | 210.47 | ||
Support 4 (S4) | 208.74 |